COVID-19 trials registries data warehouse

 Return to trial list

Trial - ChiCTR2000031834


Column Value
Trial registration number ChiCTR2000031834
Full text link
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

First author
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Li Jianan

Contact
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

lijianan@njmu.edu.cn

Registration date
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2020-04-11

Recruitment status
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not recruiting

Study design
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

RCT

Allocation
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Randomized

Design
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Parallel

Masking
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Open label

Center
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

unclear

Study aim
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Long covid

Inclusion criteria
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

1. Discharged patients with COVID-19 pneumonia, 2. With dyspnea symptom (mMRC 2~3), 3. Aged 18~75 years old, 4. Have and can use smart phone (study subjects or family members), 5. Obtain the consent of the subjects or legal representative and sign the informed consent.

Exclusion criteria
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

1. Dyspnea scale mMRC 0~1 or 4, 2. Resting heart rate>100bpm, 3. Adjusting dosage of drugs which affect cardiopulmonary function or heart rate (such as: trimetazidine, salbutamol, beta-blocker), 4. Combined uncontrolled chronic disease, such as uncontrolled hypertension (resting BP=160100mmHg), uncontrolled diabetes (random blood glucose>16.7 mmol/l, HbA1C>7.0%), 5. Combined severe organic disease, such as unstable hemodynamic heart disease, heart failure with limited movement (previous diagnosis, or have clinical symptoms of heart failure, after consultation by cardiologist), 6. Cerebrovascular disease occurred within the past 6 months, 7. Active stage of digestive ulcer, thyroid dysfunction, or active tuberculosis, 8. Chronic kidney disease >=stage 3 (eGFR<60ml/min), 9. Have received intra-articular drug injection or surgical treatment in the lower extremity within the past 6 months, 10. Poor compliance, unable to cooperate with assessment or training, 11. Unable to walk independently with auxiliary, 12. Combined mental disease that prevents patients from living independently or receiving treatment, 13. Alcohol abuse or illegal drug use history, 14. Pregnancy, nursing or preparing for pregnancy (including male subjects), 15. Have participated in other clinical trials within the past 3 months.

Number of arms
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

2

Funding
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Jiangsu Province Hospital

Inclusion age min
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

18

Inclusion age max
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

75

Countries
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

China

Type of patients
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Patients recovered from covid

Severity scale
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

N/A

Total sample size
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

120

primary outcome
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Total distances of 6 minutes walk test;

Notes
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

| Declared number of arm (2.0) differs from found arms (3.0)

Phase
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

Not reported

Arms
Last imported at : Oct. 26, 2020, 8:29 a.m.
Source : International Clinical Trials Registry Platform (ICTRP)

[{"arm_notes": "", "treatment_id": 488, "treatment_name": "Exercise rehabilitation", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 961, "treatment_name": "Patient education", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}]